LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Начало・Списък с акции・Moderna Inc

Moderna Inc

Затворен

Сектор Здравеопазване

72.88 -0.48

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

71.91

Максимум

73.08

Ключови измерители
By Trading Economics
Приходи	-104M -1.3B
Продажби	-167B 241M
P/E Средно за сектора	35.86 103.001
EPS	-3.33
Марж на печалбата	-530.705
Служители	5,600
EBITDA	-109M -1.2B

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+76.62 upside

Дивиденти
By Dow Jones
Следващи печалби	31.10.2024 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-65M 30B
Предишно отваряне	73.36
Предишно затваряне	72.88

Настроения в новините

By Acuity

31%

69%

58 / 365 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Weak Bullish Evidence

71.62 / 77.46 Подкрепа & съпротива

Moderna Inc Графика

Свързани новини

13.12.2023 г., 13:16 ч. UTC

Значими двигатели на пазара

Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer

14.10.2023 г., 00:02 ч. UTC

Горещи акции

Stocks to Watch: Pfizer, Moderna, Lululemon Athletica

11.09.2023 г., 11:39 ч. UTC

Значими двигатели на пазара

Immatics Shares Rise Premarket on Collaboration With Moderna

6.09.2024 г., 11:00 ч. UTC

Топ новини

Pandemic Darling Moderna Needs a Reality Check -- Heard on the Street -- WSJ

3.09.2024 г., 04:00 ч. UTC

Топ новини

Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring -- Barrons.com

23.08.2024 г., 18:38 ч. UTC

Топ новини

The U.S. Is Bringing Back Free Covid Tests This Fall -- Barrons.com

2.08.2024 г., 21:29 ч. UTC

Топ новини

The Score: CrowdStrike, Apple, Intel and More Stocks That Defined the Week -- WSJ

1.08.2024 г., 10:30 ч. UTC

Топ новини

Moderna Cuts Revenue Guidance Amid Steeper Competition -- Barrons.com

3.07.2024 г., 14:18 ч. UTC

Придобивния, сливания и поглъщания

GSK Will Pay Up to $1.5 Billion for CureVac's mRNA Vaccines -- Barrons.com

30.05.2024 г., 19:45 ч. UTC

Топ новини

Bird Flu Confirmed in Third Farmworker. It's the First Case With Respiratory Symptoms. -- Barrons.com

29.05.2024 г., 15:56 ч. UTC

Печалби

Придобивния, сливания и поглъщания

The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why. -- Barrons.com

10.05.2024 г., 20:11 ч. UTC

Печалби

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10.05.2024 г., 14:49 ч. UTC

Печалби

Горещи акции

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

2.05.2024 г., 13:46 ч. UTC

Печалби

Горещи акции

Stocks to Watch Thursday: Carvana, NIO, Qualcomm, Peloton -- WSJ

2.05.2024 г., 10:31 ч. UTC

Печалби

Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout? -- IBD

2.05.2024 г., 09:08 ч. UTC

Горещи акции

Stocks to Watch Thursday: Shell, Novo Nordisk, Apple -- WSJ

28.02.2024 г., 14:14 ч. UTC

Печалби

Novavax Stock Sinks as Revenue Misses Estimates in 'Transition Year' -- Barrons.com

22.02.2024 г., 16:00 ч. UTC

Топ новини

Moderna Is Pivoting From Covid and the Results Are on Their Way -- Heard on the Street -- WSJ

22.02.2024 г., 12:40 ч. UTC

Печалби

Moderna Stock Jumps on Surprise Profit After Earnings Beat. What to Expect in 2024. -- Barrons.com

2.11.2023 г., 16:53 ч. UTC

Печалби

Moderna Tumbles As Light Guidance And Steep Losses Overshadow Sales Beat -- IBD

2.11.2023 г., 08:58 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Qualcomm, PayPal, SolarEdge, Roku, DoorDash, E.l.f. Beauty, and More -- Barrons.com

31.10.2023 г., 16:35 ч. UTC

Топ новини

Печалби

Nevermind Covid, Investors Want a Pfizer Obesity Pill -- Heard on the Street -- WSJ

17.10.2023 г., 10:00 ч. UTC

Топ новини

Pfizer Looks for a Covid Bottom -- Heard on the Street -- WSJ

26.09.2023 г., 09:30 ч. UTC

Топ новини

The Big Pharma Stock Trade: Weight Loss Is In, Covid-19 Is Out -- WSJ

13.09.2023 г., 12:00 ч. UTC

Топ новини

Moderna Rises on Positive Results From Flu Vaccine, and Other Plans to Move Beyond Covid -- Barrons.com

12.09.2023 г., 13:00 ч. UTC

Топ новини

CDC Advisers Weigh Covid-19 Booster Guidance as Latest Variants Spread -- WSJ

11.09.2023 г., 18:27 ч. UTC

Топ новини

FDA Approves Newest Covid-19 Boosters -- Update

11.09.2023 г., 17:55 ч. UTC

Топ новини

FDA Approves Newest Covid-19 Boosters -- WSJ

11.09.2023 г., 11:24 ч. UTC

Значими двигатели на пазара

Immatics Shares Rise Premarket on Collaboration With Moderna >IMTX

Сравнение с други в отрасъла

Ценова промяна

Moderna Inc Прогноза

Ценова цел

By TipRanks

76.62% нагоре

12-месечна прогноза

Среден 129.71 USD 76.62%

Висок 310 USD

Нисък 58 USD

Според 19 анализатори от Wall Street, предложили 12-месечна ценова цел за Moderna Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

19 ratings

Купи

Задържане

Продай

Според 19 анализатори, дали борсови рейтинги на Moderna Inc през последните 3 месеца.

Техническа оценка

By Trading Central

71.62 / 77.46Подкрепа & съпротива

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Настроение

By Acuity

58 / 365 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Moderna Inc

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.